Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 28.73%
March 31, 2026 32.20%
December 31, 2025 32.35%
September 30, 2025 26.85%
June 30, 2025 30.25%
March 31, 2025 30.58%
December 31, 2024 31.08%
September 30, 2024 29.60%
June 30, 2024 33.57%
March 31, 2024 30.00%
December 31, 2023 31.63%
September 30, 2023 30.71%
June 30, 2023 30.31%
March 31, 2023 32.22%
December 31, 2022 29.43%
September 30, 2022 29.31%
June 30, 2022 31.01%
March 31, 2022 30.56%
December 31, 2021 26.24%
September 30, 2021 26.88%
June 30, 2021 30.84%
March 31, 2021 29.55%
December 31, 2020 27.19%
September 30, 2020 27.32%
June 30, 2020 30.30%
Date Value
March 31, 2020 31.03%
December 31, 2019 29.49%
September 30, 2019 28.28%
June 30, 2019 31.39%
March 31, 2019 32.82%
December 31, 2018 31.01%
September 30, 2018 31.73%
June 30, 2018 32.20%
March 31, 2018 32.42%
December 31, 2017 33.28%
September 30, 2017 33.05%
June 30, 2017 34.24%
March 31, 2017 32.65%
December 31, 2016 33.58%
September 30, 2016 33.60%
June 30, 2016 35.50%
March 31, 2016 32.34%
December 31, 2015 30.95%
September 30, 2015 31.47%
June 30, 2015 33.14%
March 31, 2015 31.67%
December 31, 2014 31.22%
September 30, 2014 30.82%
June 30, 2014 31.80%
March 31, 2014 29.26%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
LifeMD, Inc. 79.67%
Retrieve Medical Holdings, Inc. --
Lakefront Biotherapeutics 24.48%
UCB SA - ADR --
Fagron NV --

Gross Profit Margin (Quarterly) Related Metrics